Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Estraderm TTS 25 patches
0604011G0BCABBA
|
Estraderm | Estradiol | Endocrine System | No data available |
|
Estraderm TTS 50 patches
0604011G0BCAABL
|
Estraderm | Estradiol | Endocrine System | No data available |
|
Estradiol 100mg implant
0604011G0AAACAC
|
Estradiol (Systemic) | Estradiol | Endocrine System | No data available |
|
Estradiol 150micrograms/dose nasal spray
0604011G0AABSBS
|
Estradiol (Systemic) | Estradiol | Endocrine System | No data available |
|
Estradiol 25mg implant
0604011G0AAAAAA
|
Estradiol (Systemic) | Estradiol | Endocrine System | No data available |
|
Estradiol 25microgram pessaries
0702010G0AAAAAA
|
Estradiol (Vaginal) | Estradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Estradiol 2mg vaginal ring
0702010G0AAAEAE
|
Estradiol (Vaginal) | Estradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Estradiol 30microg/Norethist 95microg/24hours ptch
0604011L0AABPBP
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 40microg/24hours ptch and Dydrogesterone 10mg tab
0604011L0AAAUAU
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 40microg/Norethist 130microg/24hours ptch
0604011L0AABNBN
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 50mg implant
0604011G0AAABAB
|
Estradiol (Systemic) | Estradiol | Endocrine System | No data available |
|
Estradiol 50microg/24hours ptch and Norethist 1mg tab
0604011L0AAAJAJ
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 50microg/24hours ptch and Norethist acet 1mg tab
0604011L0AABBBB
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 80microg/24hours ptch and Dydrogesterone 10mg tab
0604011L0AAAQAQ
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol acetate 1.25mg vaginal ring
0702010G0AAAFAF
|
Estradiol (Vaginal) | Estradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Estradiol valerate 2mg / Norethisterone 700microgram tablets
0604011L0AAARAR
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradot Conti 30/95 transdermal patches
0604011L0CDABBP
|
Estradot Conti | Estradiol with progestogen | Endocrine System | No data available |
|
Estradot Conti 40/130 transdermal patches
0604011L0CDAABN
|
Estradot Conti | Estradiol with progestogen | Endocrine System | No data available |
|
Estramustine 140mg capsules
0801010J0AAAAAA
|
Estramustine phosphate | Estramustine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Estrapak 50
0604011L0BBAABB
|
Estrapak 50 | Estradiol with progestogen | Endocrine System | No data available |
|
Estring 2mg vaginal ring
0702010G0BDAAAE
|
Estring | Estradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Estriol 1mg tablets
0604011M0AAABAB
|
Estriol (Systemic) | Estriol | Endocrine System | No data available |
|
Estropipate 1.5mg tablets
0604011R0AAAAAA
|
Estropipate | Estropipate | Endocrine System | No data available |
|
Eszopiclone 1mg tablets
0401010AEAAAAAA
|
Eszopiclone | Eszopiclone | Central Nervous System | No data available |
|
Eszopiclone 2mg tablets
0401010AEAAABAB
|
Eszopiclone | Eszopiclone | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.